Praxis Medical Insights

Immediate Management of Alcohol Withdrawal Tremors

The American Association for the Study of Liver Diseases recommends benzodiazepines as the first-line treatment for alcohol withdrawal syndrome, which commonly presents with tremors within 6-24 hours after the last drink, with a symptom-triggered regimen to prevent medication accumulation 1, 3
The European Association for the Study of the Liver suggests that short and intermediate-acting benzodiazepines, such as lorazepam, are safer than long-acting ones in patients with potential liver dysfunction 1
Benzodiazepines should not be continued beyond 10-14 days due to potential for abuse, especially in patients with alcohol use disorder, as recommended by the American College of Gastroenterology 3

The French National Agency for Medicines and Health Products Safety has issued a temporary recommendation for baclofen use, not exceeding 80 mg/day, for alcohol use disorder treatment, and it has demonstrated safety and efficacy in promoting alcohol abstinence in patients with alcoholic liver disease and cirrhosis 2, 3
Topiramate is another promising option that has demonstrated efficacy in reducing heavy drinking and may decrease liver enzyme levels, though it has not been specifically tested in patients with alcoholic liver disease, according to the American Gastroenterological Association 2, 3

Naltrexone should be avoided in patients with alcoholic liver disease due to risk of hepatotoxicity, as warned by the National Institute on Alcohol Abuse and Alcoholism 2
Disulfiram should not be used in patients with severe alcoholic liver disease due to possible hepatotoxicity, as cautioned by the American Association for the Study of Liver Diseases 2, 4

Thiamine supplementation, 100-300 mg/day for 4-12 weeks, is crucial to prevent Wernicke encephalopathy, and should be administered before any glucose-containing IV fluids, as recommended by the European Society for Clinical Nutrition and Metabolism 2

Regular liver function tests should be performed to monitor improvement and medication effects, and alcohol abstinence remains the most important intervention for improving outcomes in alcohol-related liver disease, according to the American Liver Foundation 2
The CIWA-Ar score can help assess withdrawal severity and guide treatment intensity, with a score >8 indicating moderate AWS and a score ≥15 indicating severe AWS, as suggested by the American Society of Addiction Medicine 1